Healthcare and Pharmaceuticals industry

Pneumococcal Conjugate Vaccine (PCV) Market By Type, Size, And Application: Global Opportunity Analysis And Industry Forecast, 2020-2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Pneumococcal Conjugate Vaccine (PCV) Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020. 

The Pneumococcal Conjugate Vaccine (PCV) Market report highlights product development and growth strategies such as mergers and acquisitions adopted by market players along with SWOT Analysis, PEST, and Porter’s Five Forces analyses of the Pneumococcal Conjugate Vaccine (PCV) Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Pfizer
  • GSK
  • Sanofi
  • Merck
  • Walvax Biotechnology
  • Royal (Wuxi) Bio-Pharmaceutical
  • Zhifei Biologic
  • Serum Institute of India

By Product Type, the market is primarily segmented into:

  • 23-valent Vaccine
  • 10-valent Vaccine
  • 7-valent Vaccine
  • 13-valent Vaccine

By Applications, the market is segmented into:

  • Child
  • Adult

The report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

The objective of the Pneumococcal Conjugate Vaccine (PCV) Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Pneumococcal Conjugate Vaccine (PCV) Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Pneumococcal Conjugate Vaccine (PCV) Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of-the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact the growth of the Pneumococcal Conjugate Vaccine (PCV) Market

The Pneumococcal Conjugate Vaccine (PCV) Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Pneumococcal Conjugate Vaccine (PCV) Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type, and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

1 Report Overview


1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pneumococcal Conjugate Vaccine (PCV) Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application: 2020 VS 2026
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Pneumococcal Conjugate Vaccine (PCV) Market
1.6.1 How the Covid-19 is Affecting the Pneumococcal Conjugate Vaccine (PCV) Market
1.6.1.1 Pneumococcal Conjugate Vaccine (PCV) Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Pneumococcal Conjugate Vaccine (PCV) Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered


2 Global Growth Trends by Regions


2.1 Pneumococcal Conjugate Vaccine (PCV) Market Perspective (2015-2026)
2.2 Pneumococcal Conjugate Vaccine (PCV) Market Growth Trends by Regions
2.2.1 Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pneumococcal Conjugate Vaccine (PCV) Market Historic Market Share by Regions (2015-2020)
2.2.3 Pneumococcal Conjugate Vaccine (PCV) Market Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Pneumococcal Conjugate Vaccine (PCV) Market Growth Strategy
2.3.6 Primary Interviews with Key Pneumococcal Conjugate Vaccine (PCV) Market Players (Opinion Leaders)


3 Competition Landscape by Key Players


3.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Market Players by Market Size
3.1.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Market Players by Revenue (2015-2020)
3.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Revenue Market Share by Players (2015-2020)
3.1.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio
3.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pneumococcal Conjugate Vaccine (PCV) Market Revenue in 2019
3.3 Pneumococcal Conjugate Vaccine (PCV) Market Key Players Head office and Area Served
3.4 Key Players Pneumococcal Conjugate Vaccine (PCV) Market Product Solution and Service
3.5 Date of entering into Pneumococcal Conjugate Vaccine (PCV) Market
3.6 Mergers & Acquisitions, Expansion Plans


4 Breakdown Data by Type (2015-2026)


4.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Historic Market Size by Type (2015-2020)
4.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecasted Market Size by Type (2021-2026)


5 Pneumococcal Conjugate Vaccine (PCV) Market Breakdown Data by Application (2015-2026)


5.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020)
5.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecasted Market Size by Application (2021-2026)


6 North America


6.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size (2015-2020)
6.2 Pneumococcal Conjugate Vaccine (PCV) Market Key Players in North America (2019-2020)
6.3 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020)
6.4 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020)


7 Europe


7.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size (2015-2020)
7.2 Pneumococcal Conjugate Vaccine (PCV) Market Key Players in Europe (2019-2020)
7.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020)
7.4 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020)


8 China


8.1 China Pneumococcal Conjugate Vaccine (PCV) Market Size (2015-2020)
8.2 Pneumococcal Conjugate Vaccine (PCV) Market Key Players in China (2019-2020)
8.3 China Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020)
8.4 China Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020)


9 Japan


9.1 Japan Pneumococcal Conjugate Vaccine (PCV) Market Size (2015-2020)
9.2 Pneumococcal Conjugate Vaccine (PCV) Market Key Players in Japan (2019-2020)
9.3 Japan Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020)
9.4 Japan Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020)


10 Southeast Asia


10.1 Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size (2015-2020)
10.2 Pneumococcal Conjugate Vaccine (PCV) Market Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020)
10.4 Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020)


11 India


11.1 India Pneumococcal Conjugate Vaccine (PCV) Market Size (2015-2020)
11.2 Pneumococcal Conjugate Vaccine (PCV) Market Key Players in India (2019-2020)
11.3 India Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020)
11.4 India Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020)


12 Central & South America


12.1 Central & South America Pneumococcal Conjugate Vaccine (PCV) Market Size (2015-2020)
12.2 Pneumococcal Conjugate Vaccine (PCV) Market Key Players in Central & South America (2019-2020)
12.3 Central & South America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020)
12.4 Central & South America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020)


13 Key Players Profiles


13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Pneumococcal Conjugate Vaccine (PCV) Market Introduction
13.4 Pneumococcal Conjugate Vaccine (PCV) Market Business (2015-2020)
13.5 Recent Development


14 Analyst's Viewpoints/Conclusions


15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details


List of Table


Table 1. Pneumococcal Conjugate Vaccine (PCV) Market Key Market Segments
Table 2. Key Players Covered: Ranking by Pneumococcal Conjugate Vaccine (PCV) Market Revenue
Table 3. Ranking of Global Top Pneumococcal Conjugate Vaccine (PCV) Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Pneumococcal Conjugate Vaccine (PCV) Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Pneumococcal Conjugate Vaccine (PCV) Market Players to Combat Covid-19 Impact
Table 10. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions (2015-2020)
Table 14. Global Pneumococcal Conjugate Vaccine (PCV) Market Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Pneumococcal Conjugate Vaccine (PCV) Market Growth Strategy
Table 20. Main Points Interviewed from Key Pneumococcal Conjugate Vaccine (PCV) Market Players
Table 21. Global Pneumococcal Conjugate Vaccine (PCV) Market Revenue by Players (2015-2020) (Million US$)
Table 22. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players (2015-2020)
Table 23. Global Top Pneumococcal Conjugate Vaccine (PCV) Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) Market as of 2019)
Table 24. Global Pneumococcal Conjugate Vaccine (PCV) Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Pneumococcal Conjugate Vaccine (PCV) Market Product Solution and Service
Table 27. Date of entering into Pneumococcal Conjugate Vaccine (PCV) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020) (Million US$)
Table 30. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Share by Type (2015-2020)
Table 31. Global Pneumococcal Conjugate Vaccine (PCV) Market Revenue Market Share by Type (2021-2026)
Table 31. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Share by Application (2015-2020)
Table 33. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020) (Million US$)
Table 34. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Share by Application (2021-2026)
Table 35. North America Key Players Pneumococcal Conjugate Vaccine (PCV) Market Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Pneumococcal Conjugate Vaccine (PCV) Market Share (2019-2020)
Table 37. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020) (Million US$)
Table 38. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2015-2020)
Table 39. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020) (Million US$)
Table 40. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2015-2020)
Table 41. Europe Key Players Pneumococcal Conjugate Vaccine (PCV) Market Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Pneumococcal Conjugate Vaccine (PCV) Market Share (2019-2020)
Table 43. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2015-2020)
Table 45. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2015-2020)
Table 47. China Key Players Pneumococcal Conjugate Vaccine (PCV) Market Revenue (2019-2020) (Million US$)
Table 48. China Key Players Pneumococcal Conjugate Vaccine (PCV) Market Share (2019-2020)
Table 49. China Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020) (Million US$)
Table 50. China Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2015-2020)
Table 51. China Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020) (Million US$)
Table 52. China Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2015-2020)
Table 53. Japan Key Players Pneumococcal Conjugate Vaccine (PCV) Market Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Pneumococcal Conjugate Vaccine (PCV) Market Share (2019-2020)
Table 55. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2015-2020)
Table 57. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Pneumococcal Conjugate Vaccine (PCV) Market Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Pneumococcal Conjugate Vaccine (PCV) Market Share (2019-2020)
Table 61. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2015-2020)
Table 63. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2015-2020)
Table 65. India Key Players Pneumococcal Conjugate Vaccine (PCV) Market Revenue (2019-2020) (Million US$)
Table 66. India Key Players Pneumococcal Conjugate Vaccine (PCV) Market Share (2019-2020)
Table 67. India Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020) (Million US$)
Table 68. India Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2015-2020)
Table 69. India Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020) (Million US$)
Table 70. India Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Pneumococcal Conjugate Vaccine (PCV) Market Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Pneumococcal Conjugate Vaccine (PCV) Market Share (2019-2020)
Table 73. Central & South America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2015-2020)
Table 75. Central & South America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2015-2020)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Pneumococcal Conjugate Vaccine (PCV) Market Business (2015-2020) (Million US$)
Table 81. Recent Development


List of Figures


Figure 1. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Type: 2020 VS 2026
Figure 2. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application: 2020 VS 2026
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Pneumococcal Conjugate Vaccine (PCV) Market Report Years Considered
Figure 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions: 2020 VS 2026
Figure 10. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players in 2019
Figure 13. Global Top Pneumococcal Conjugate Vaccine (PCV) Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Market Revenue in 2019
Figure 15. North America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.